Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost

about

The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

P2860

Q55033689-84AB3AC0-894E-4F94-BC57-AA7FC080C7E1

P2860

Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost

Item

http://www.wikidata.org/entity/Q37176535

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alpha/beta (α/β) ratio for pro ...... herapy and brachytherapy boost

@en

Alpha/beta

@nl

type

Item

label

Alpha/beta (α/β) ratio for pro ...... herapy and brachytherapy boost

@en

Alpha/beta

@nl

prefLabel

Alpha/beta (α/β) ratio for pro ...... herapy and brachytherapy boost

@en

Alpha/beta

@nl

P1476

Alpha/beta (α/β) ratio for pro ...... herapy and brachytherapy boost

@en

P2093

Beata Smolska-Ciszewska

http://www.w3.org/2001/XMLSchema#string

Brygida Bialas

http://www.w3.org/2001/XMLSchema#string

Jeremy M G Taylor

http://www.w3.org/2001/XMLSchema#string

Katarzyna Behrendt

http://www.w3.org/2001/XMLSchema#string

Marzena Gawkowska-Suwinska

http://www.w3.org/2001/XMLSchema#string

Philip S Boonstra

http://www.w3.org/2001/XMLSchema#string

Tomasz Dworzecki

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?

Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?

A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer.

Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer.

P304

20150957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20150957

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1061

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rafal Suwinski

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26903392

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

brachytherapy

P932

4985475

http://www.w3.org/2001/XMLSchema#string

Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost

about

P2860

P2860

Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932